InvestorsHub Logo
icon url

otodoc

09/04/12 8:45 PM

#62568 RE: BonelessCat #62566

I have to differ with you doc - by any definition you can find, nanoviricides are a drug, mechanism of action notwithstanding. I agree with you that the likelihood of toxicity in humans is likely to be very low.
Someone who has Seymour's ear should ask them why they think the antibody response is greater via the oral route - pharmakokinetics vs. local immune factors
Here is an interesting reference:
http://www.ncbi.nlm.nih.gov/pubmed/19428864
The earlier reference to flucide in a neti pot may be right on the money, although it might feel like getting soap up yr nose.
icon url

jg35

09/05/12 11:01 AM

#62585 RE: BonelessCat #62566

Nanoviricides are certainly drugs, just with a different mechanism of action from other drugs. (At the level of atoms *any* drug can be regarded as a kind of nanomachine.) I am certain that the FDA agrees with me on this issue.

Do I think it likely that nanoviricides are safe in humans? Yes. Do I think the odds of nanoviricides having serious negative side effects are only one in a billion, the same as the chances of you being hit by a bus tomorrow? No. Ask me the same questions about efficacy and again I'd answer "Yes" and "No". Biomedicine has a way of surprising people, often on the downside. The FDA (and the regulatory agencies in other governments) insists upon careful testing of toxicity and efficacy in humans before nanoviricides can be used precisely because they do not really know how safely and well nanoviricides will work in people, contrary to the confident assertions of people on this board.

I own shares of this stock. I see it as a lottery ticket with positive expectation. But I'm not going to put so much money in this stock that I'd be seriously hurting if it goes to zero.